The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis

Liver International : Official Journal of the International Association for the Study of the Liver
Detlef SchuppanNezam H Afdhal

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an umbrella term for a series of hepatic pathologies that begin with relatively benign steatosis and can, with appropriate triggers, lead to the serious entity of non-alcoholic steatohepatitis (NASH). This sets the stage for liver fibrosis and finally the development of cirrhosis in up to 20% of patients with NASH. NAFLD, already among the most common diseases in industrialized countries, is increasing in prevalence and roughly affects 30% of US adults and 10% of US children alone. NAFLD is strongly associated with insulin resistance (IR) and represents the hepatic manifestation of the metabolic syndrome. Indeed, treatments aimed at reducing IR are the current mainstay of therapeutic approaches to NAFLD. While lifestyle interventions may produce limited degrees of success, there remains an urgent need for improved pharmacological therapies. Emerging diagnostic and therapeutic opportunities as well as future developments in NAFLD, NASH and liver fibrosis were discussed by a panel of experts and are presented herein. Promising novel therapeutic targets include inhibitors of dipeptidyl peptidase 4 and the renin-angiotensin system. However, improved non-invasive technologies to diagnose ...Continue Reading

References

Jan 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E E PowellL W Powell
Jan 1, 1986·Scandinavian Journal of Gastroenterology·R HultcrantzL H Nilsson
Sep 1, 1982·Forensic Science International : Synergy·B Kringsholm, P Christoffersen
Dec 5, 1995·Biochemical and Biophysical Research Communications·K LösterW Reutter
Nov 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P AnguloK D Lindor
Sep 21, 2000·European Journal of Clinical Investigation·P L LakatosF Szalay
Mar 10, 2001·The American Journal of Gastroenterology·S H CaldwellB L Sheppard
Sep 25, 2001·Lancet·G MarchesiniN Melchionda
Jun 11, 2002·Biochemical and Biophysical Research Communications·Carolyn F Deacon, Jens J Holst
Dec 19, 2002·Journal of Biomedicine & Biotechnology·P. M. L. MannaR. S. Gomez
Jun 18, 2003·The American Journal of Gastroenterology·Jeanne M ClarkAnna Mae Diehl
Jul 29, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marcelo KugelmasCraig J McClain
Jul 29, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jason M HuiJacob George
Sep 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Brent A Neuschwander-TetriBruce R Bacon
Nov 26, 2003·The American Journal of Gastroenterology·Stephen A HarrisonSteven Schenker
Jan 31, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kittichai PromratJay H Hoofnagle
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Keith D LindorPatrick Colin
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jeffrey D BrowningHelen H Hobbs
Dec 31, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Arun J SanyalAlan S Mills
May 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David E KleinerUNKNOWN Nonalcoholic Steatohepatitis Clinical Research Network
Jun 9, 2005·Gastroenterology·Vlad RatziuUNKNOWN LIDO Study Group
Jun 23, 2005·Journal of Magnetic Resonance Imaging : JMRI·Miwa KoinumaHitoshi Shibuya
Sep 6, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Shigeki TsukadaRichard A Rippe
Sep 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xin Maggie WangMark D Gorrell
Dec 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xiaokun DingFrank A Anania
Jan 10, 2006·Drugs·Anna J Battershill, Lesley J Scott
Mar 18, 2006·Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine·Shinji NaganawaTakeo Ishigaki
Mar 29, 2006·Hypertension·Arya M Sharma
Jun 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna WieckowskaAriel E Feldstein
Sep 1, 2006·Current Treatment Options in Gastroenterology·Eve A Roberts, Jason Yap
Sep 19, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·John McHutchisonUNKNOWN International Fibrosis Group Meeting Participants
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Raphael B MerrimanNathan M Bass
Nov 9, 2006·Comparative Hepatology·Nicholas A ShackelGeoffrey W McCaughan
Dec 1, 2006·The New England Journal of Medicine·Renata BelfortKenneth Cusi
Dec 13, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jean-François DufourUNKNOWN Swiss Association for the Study of the Liver
Jan 24, 2007·Gastroenterology·Tsuguhito OtaShuichi Kaneko

❮ Previous
Next ❯

Citations

Nov 22, 2014·Dermatologic Clinics·Marisa Kardos Garshick, Alexa Boer Kimball
Dec 7, 2016·Scientific Reports·Yohei KanamoriMasayuki Funaba
Oct 30, 2012·Acta Pharmacologica Sinica·En-tong YiCheng-hong Yin
Nov 26, 2015·The Proceedings of the Nutrition Society·I Rodriguez-RamiroA M Minihane
Sep 21, 2013·Medical Molecular Morphology·Thomas KleinHiroyuki Yoneyama
Oct 18, 2011·Current Opinion in Lipidology·Jörn M Schattenberg, Detlef Schuppan
May 24, 2012·Current Opinion in Lipidology·Anthony S Wierzbicki, Jude Oben
Oct 13, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Takaaki SugiharaYoshikazu Murawaki
May 7, 2014·World Journal of Hepatology·Sara HeebøllHenning Grønbæk
May 31, 2017·Current Medicinal Chemistry·José TeixeiraPaulo J Oliveira
Dec 15, 2012·Endocrine Reviews·K H WilliamsS M Twigg
May 13, 2020·Journal of Diabetes·Margaret F BassendineMark D Gorrell
Aug 30, 2016·World Journal of Gastroenterology : WJG·Hong YaoJin-Yong Peng
Mar 3, 2012·American Journal of Physiology. Gastrointestinal and Liver Physiology·Yong Ook Kim, Detlef Schuppan
Feb 18, 2016·Digestive Diseases and Sciences·Lei ChenHui-Qing Jiang
Apr 9, 2013·International Journal of Experimental Pathology·Holger CynisHans-Ulrich Demuth
Jul 7, 2015·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Na AoJian Du
Jan 12, 2021·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Zhenyu WangShaoling Lin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.